Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.32
Delayed Data
As of 4:02pm ET
 +0.01 / +0.76%
Today’s Change
0.97
Today|||52-Week Range
2.02
-30.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line5.6M-29.2M-42.7M-35.7M
 
 
 
 
 
Depreciation176.5K200.2K404.2K500.2K
 
 
 
 
 
Total Other Cash Flow-21.5M4.0M5.4M7.7M
 
 
 
 
 
Funds From Operations-15.8M-24.9M-36.9M-27.6M
 
 
 
 
 
Funds From/For Other Operating Expenses254.6K-1.0M-1.3M1.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-16.0M-23.9M-35.6M-29.1M
 
 
 
 
 
 
InvestingIncrease In Investments0.000.000.00-333.3K
 
 
Capital Expenditures-183.8K-663.3K-1.2M-1.1M
 
 
 
 
 
Fixed Asset Disposal30.2M0.000.00--
 
 
Net Assets From Acquisitions -2.8M0.000.000.00
 
 
Net Cash Flow Investing27.2M-671.8K-1.3M-1.5M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings7.0M3.8M27.8M28.2M
 
 
 
 
 
Long Term Debt Reduction-71.0K-1.3M-6.0M-25.0M
 
 
 
 
 
Net Proceeds Stock Sale7.2M2.7M39.6M88.0K
 
 
 
 
 
Common Preferred Redeemed0.00-100.9K0.000.00
 
 
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total-100.0K-100.0K0.000.00
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing3.0M14.6K659.0K130.5K
 
 
 
 
 
Net Cash Flow - Financing11.1M5.1M60.7M3.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--0.000.000.00--
 
Net Change In Cash22.2M-19.5M23.8M-27.5M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account